Roivant Sciences Ltd (ROIV)
Pretax margin
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | -591,805 | -580,204 | 4,752,649 | 4,649,671 | 4,253,433 | 4,265,670 | -1,214,747 | -1,201,142 | -1,224,834 | -1,337,094 | -1,261,064 | -1,172,547 | -923,747 | -1,195,454 | -1,165,228 | -992,776 | -898,547 | -335,364 |
| Revenue (ttm) | US$ in thousands | 76,195 | 97,555 | 125,677 | 158,303 | 124,795 | 123,241 | 103,153 | 78,585 | 61,280 | 43,127 | 50,416 | 51,870 | 55,286 | 61,209 | 42,618 | 29,954 | 23,795 | 8,649 |
| Pretax margin | -776.70% | -594.75% | 3,781.64% | 2,937.20% | 3,408.34% | 3,461.24% | -1,177.62% | -1,528.46% | -1,998.75% | -3,100.36% | -2,501.32% | -2,260.55% | -1,670.85% | -1,953.07% | -2,734.12% | -3,314.34% | -3,776.20% | -3,877.49% |
March 31, 2025 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-591,805K ÷ $76,195K
= -776.70%
Roivant Sciences Ltd's pretax margin has shown a fluctuating trend over the past few years. The company reported negative pretax margins ranging from -3,877.49% in December 2020 to -1,177.62% in September 2023. This indicates that the company's operating expenses and taxes exceeded its gross revenue during these periods.
However, there was a significant improvement in the pretax margin, with positive margins recorded in December 2023 and March 2024 at 3,461.24% and 3,408.34%, respectively. This suggests that the company experienced a substantial increase in profitability during these quarters.
Subsequently, the pretax margin decreased again and turned negative in the following quarters, reaching -776.70% in March 2025. This reversal could indicate a decline in profitability or an increase in operating expenses compared to revenue during this period.
Overall, Roivant Sciences Ltd's pretax margin has displayed a mix of negative and positive trends, highlighting the company's varying levels of profitability and operational efficiency over the analyzed timeframe.
Peer comparison
Mar 31, 2025